ELAN
Price
$22.14
Change
+$0.37 (+1.70%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
11.22B
35 days until earnings call
Intraday BUY SELL Signals
VTRS
Price
$17.61
Change
+$0.15 (+0.86%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
20.98B
38 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELAN vs VTRS

ELAN vs VTRS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ELAN vs. VTRS commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and VTRS is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ELAN vs VTRS: Fundamental Ratings
ELAN
VTRS
OUTLOOK RATING
1..100
5620
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
10050
SMR RATING
1..100
9291
PRICE GROWTH RATING
1..100
5826
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
n/a55

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (12) in the null industry is significantly better than the same rating for ELAN (92) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew significantly faster than ELAN’s over the last 12 months.

VTRS's Profit vs Risk Rating (50) in the null industry is somewhat better than the same rating for ELAN (100) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew somewhat faster than ELAN’s over the last 12 months.

VTRS's SMR Rating (91) in the null industry is in the same range as ELAN (92) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew similarly to ELAN’s over the last 12 months.

VTRS's Price Growth Rating (26) in the null industry is in the same range as ELAN (58) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew similarly to ELAN’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is in the same range as ELAN (1) in the Agricultural Commodities Or Milling industry. This means that VTRS’s stock grew similarly to ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANVTRS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
48%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 5 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
56%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
69%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (ELAN: $21.77 vs. VTRS: $17.46)
Brand notoriety: ELAN: Notable vs. VTRS: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 86% vs. VTRS: 74%
Market capitalization -- ELAN: $11.22B vs. VTRS: $20.98B
ELAN [@Pharmaceuticals: Generic] is valued at $11.22B. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $20.98B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 1 FA rating(s) are green while VTRS’s FA Score has 3 green FA rating(s).

  • ELAN’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 3 green, 2 red.
According to our system of comparison, VTRS is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 3 TA indicator(s) are bullish while VTRS’s TA Score has 6 bullish TA indicator(s).

  • ELAN’s TA Score: 3 bullish, 5 bearish.
  • VTRS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VTRS is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а -2.60% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was +0.23% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.71%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +29.84%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 06, 2026.

VTRS is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.71% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
ELAN
Daily Signal:
Gain/Loss:
VTRS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKY46.001.31
+2.93%
Rocky Brands
NYAX48.250.54
+1.13%
Nayax Ltd
WLIIU10.58N/A
N/A
Willow Lane Acquisition Corp II
SOWG2.27-0.03
-1.09%
Sow Good Inc.
RIOT19.61-0.54
-2.68%
Riot Platforms

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with AMRX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-1.47%
AMRX - VTRS
43%
Loosely correlated
-0.35%
COLL - VTRS
36%
Loosely correlated
+0.09%
AMPH - VTRS
36%
Loosely correlated
-1.78%
TEVA - VTRS
34%
Loosely correlated
-0.73%
ELAN - VTRS
34%
Loosely correlated
-2.77%
More